drugset / Trial / NCT00198419

Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

NCT00198419 ↗

Phase 1 Completed 65 enrolled Bausch & Lomb Incorporated
NaSingle-groupOpen-labelScreening

Summary

The objective of this study was to rule out a greater than 10% incidence of hypersensitivity to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or equal to 10% hypersensitivity response was considered acceptable.

Timeline

Start
2004-03
Primary completion
2004-03
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 3 iu Other